Related Experiment Videos

The shift in the "paradigm" of the pharmacology of hypertension

Christodoulos S Flordellis1, Dimitrios Goumenos, George Kourounis

  • 1Department of Pharmacology, School of Medicine, University of Patras, Rio Patras, Greece. flordell@med.upatras.gr

Current Topics in Medicinal Chemistry
|February 18, 2004
PubMed

Insights

Hypertension treatment is evolving beyond hemodynamic control to address endothelial dysfunction and local tissue pathways. New drugs and genetic insights offer personalized strategies for managing high blood pressure.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Genetics

Background:

  • Elevated blood pressure was historically viewed as a purely hemodynamic issue, managed by inhibiting vasoconstrictor pathways like the renin-angiotensin system.
  • Recent research highlights the dissociation of endothelial dysfunction and vascular pathology from blood pressure itself.
  • Endothelial dysfunction is now recognized for its role in atherosclerosis and thrombosis, not just vascular reactivity.

Purpose of the Study:

  • To explore the evolving pharmacological approaches to hypertension management.
  • To investigate the role of endothelial function, local tissue renin-angiotensin system, and natriuretic peptides in hypertension.
  • To examine the impact of genetic polymorphisms on hypertension pathophysiology and treatment response.

Main Methods:

  • Review of recent advancements in understanding hypertension.
  • Analysis of new drug targets focusing on endothelial function, vasodilatory, and anti-proliferative pathways.
  • Exploration of genetic polymorphisms in key hypertension effectors.

Main Results:

  • New pharmacological strategies consider endothelial function and local tissue systems.
  • Drugs like Nebivolol, Carvedilol, and Omapatrilat represent a shift in therapeutic targets.
  • Identification of genetic polymorphisms (e.g., p22phox, alpha-adducin, adrenergic receptors) offers potential for personalized hypertension treatment.

Conclusions:

  • Hypertension management is shifting towards a more comprehensive approach.
  • Targeting endothelial function and utilizing novel drug classes are key advancements.
  • Genetic insights pave the way for individualized hypertension treatment strategies.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Pharmacodynamic Responses: Different Types01:03

Pharmacodynamic Responses: Different Types

Pharmacodynamics is the scientific study of a drug's biochemical or physiological influence on the body. It categorizes responses into continuous, discrete (or categorical), and time-to-event outcomes. Continuous responses yield numerical values within a certain range, such as blood pressure readings and blood glucose levels, gauging the efficacy of antihypertensive and antidiabetic drugs. Discrete responses can be binary, indicating whether a drug has an effect or not, or ordinal, exemplifying...